No Data
No Data
Skye Bioscience to Participate in Upcoming November Healthcare Investment Conferences
Is Skye Bioscience, Inc. (SKYE) the Best Russell 2000 Stock to Buy According to Analysts?
Express News | Skye Bioscience Inc : Scotiabank Initiates Coverage With Sector Outperform Rating; Price Target $20
Weight loss candidate drug nimacimab safety approved. Skye (SKYE.US) stock price soared 11%.
Skye Bioscience's stock price soared 11%, benefiting from the safety differences between its weight loss candidate drug nimacimab and novo-nordisk a/s's monlunabant.
Sector Update: Health Care Stocks Retreat Late Afternoon
Sector Update: Health Care